These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8453853)

  • 1. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium.
    Gariepy LP; Varin F; Donati F; Salib Y; Bevan DR
    Clin Pharmacol Ther; 1993 Mar; 53(3):340-7. PubMed ID: 8453853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia.
    Dresner DL; Basta SJ; Ali HH; Schwartz AF; Embree PB; Wargin WA; Lai AA; Brady KA; Savarese JJ
    Anesth Analg; 1990 Nov; 71(5):498-502. PubMed ID: 2145783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure.
    Cook DR; Freeman JA; Lai AA; Robertson KA; Kang Y; Stiller RL; Aggarwal S; Abou-Donia MM; Welch RM
    Anesth Analg; 1991 Feb; 72(2):145-50. PubMed ID: 1824669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium.
    Fisher DM; Reynolds KS; Schmith VD; Hsu J; Sokoll MD; Lennon RL; Caldwell JE
    Anesth Analg; 1999 Sep; 89(3):786-95. PubMed ID: 10475326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients.
    Koscielniak-Nielsen ZJ; Law-Min JC; Donati F; Bevan DR; Clement P; Wise R
    Anesth Analg; 1992 Jun; 74(6):845-50. PubMed ID: 1534472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical pharmacology of doxacurium in young adults and in elderly patients.
    Martlew RA; Harper NJ
    Anaesthesia; 1995 Sep; 50(9):779-82. PubMed ID: 7573867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
    Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
    Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of advanced age on the pharmacodynamics of doxacurium.
    Levy G
    Clin Pharmacol Ther; 1994 Mar; 55(3):359-62. PubMed ID: 8143401
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of doxacurium chloride (BW A938U) in children.
    Sarner JB; Brandom BW; Cook DR; Dong ML; Horn MC; Woelfel SK; Davis PJ; Rudd GD; Foster VJ; McNulty BF
    Anesth Analg; 1988 Apr; 67(4):303-6. PubMed ID: 2965532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
    Cashman JN; Luke JJ; Jones RM
    Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans.
    Plaud B; Proost JH; Wierda JM; Barre J; Debaene B; Meistelman C
    Clin Pharmacol Ther; 1995 Aug; 58(2):185-91. PubMed ID: 7648768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants.
    Hull CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():13-7. PubMed ID: 8533537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients.
    Alloul K; Whalley DG; Shutway F; Ebrahim Z; Varin F
    Anesthesiology; 1996 Feb; 84(2):330-9. PubMed ID: 8602663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of pipecuronium bromide (Arduan) in elderly surgical patients.
    Ornstein E; Matteo RS; Schwartz AE; Jamdar SC; Diaz J
    Anesth Analg; 1992 Jun; 74(6):841-4. PubMed ID: 1317685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacodynamics of doxacurium.
    Schmith VD; Fiedler-Kelly J; Abou-Donia M; Huffman CS; Grasela TH
    Clin Pharmacol Ther; 1992 Nov; 52(5):528-36. PubMed ID: 1424427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxacurium. A review of its pharmacology and clinical potential in anaesthesia.
    Faulds D; Clissold SP
    Drugs; 1991 Oct; 42(4):673-89. PubMed ID: 1723368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of doxacurium during cardiac surgery with hypothermic cardiopulmonary bypass.
    McDonagh P; Dupuis JY; Curran M; Kitts J; Wynands JE
    Can J Anaesth; 1996 Feb; 43(2):134-40. PubMed ID: 8825538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling of doxacurium: effect of input rate.
    Zhu Y; Audibert G; Donati F; Varin F
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):23-37. PubMed ID: 9353692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
    van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
    Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.